peltopepimut-Scemiplimabrecurrent/metastatic HPV16-positive head and neck cancerHPV16-positive recurrent/metastatic oropharyngeal cancer
…plimab did not increase cemiplimab’s toxicity.Conclusion Adding peltopepimut-S to cemiplimab did not improve ORR and worsened mOS in the prima…